The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults ...
The diabetes drug you've heard of for 60 years just revealed a secret — it's been working on your brain all along.
Metformin has been used for years to help people with Type 2 Diabetes control their blood sugar. Now, scientists have ...
Zacks Investment Research on MSN
Novo Nordisk's Awiqli gets FDA approval for type II diabetes
Novo Nordisk NVO announced that the FDA has approved Awiqli injection as the first and only once-weekly, long-acting basal ...
His research showed that Type 2 diabetes was caused by insulin resistance at the cellular level, a controversial idea that ...
Diabetes is one of the fastest-growing diseases in the world. We examine why diabetes is such a pervasive problem and explore ...
The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...
Kresladi becomes the first FDA-approved gene therapy for children with severe LAD-I due to biallelic variants in ITGB2, and ...
Everyday Health on MSN
Once-a-Week Insulin Shot Could Be a Game Changer for Type 2 Diabetes
Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly alternative.
March 26 (Reuters) - The U.S. Food and Drug Administration has approved Novo Nordisk's insulin injection, Awiqli, to control ...
The risk for dementia is significantly higher in people with diabetes, with the greatest risk among those with type 1 disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results